Dianthus Therapeutics, Inc. /DE/ (DNTH)

Form 4 sales, Form 144 notices and lockup dates

Sales chart range
Log in to watch DNTH
Latest sale
$2M
Sep 17 · Routine
Form 4 sales
55
On record
Form 144 notices
0
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

2
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. 1 Form 4 saleRoutine
    Jul 9 2026

    Sold 31,249 shares at $101.03 ($3.2M)

    Savitz Ryan, EVP, CFO & CBO

    10b5-1 planSold 100% of holdings ($3.2M position)0 shares left1.6x usual sizeFiling

  2. 2 Form 4 saleRoutine
    Aug 7 +29 days

    Sold 166,000 shares at $108.11 ($17.9M)

    Garcia Marino, CEO AND PRESIDENT

    10b5-1 planSold 71.8% of holdings ($25M position)65,292 shares leftFiling

  3. 3 Form 4 saleRoutine
    Aug 10 +3 days

    Sold 2,777 shares at $109.55 ($304k)

    Read Simon, Director

    10b5-1 planSold 100% of holdings ($304k position)0 shares leftFirst sale on recordFiling

  4. 4 Form 4 saleRoutine
    Aug 10 same day

    Sold 20,000 shares at $110.44 ($2.2M)

    Veness Adam M, SVP, General Counsel and Sec.

    10b5-1 planSold 100% of holdings ($2.2M position)0 shares leftFiling

  5. 5 Form 4 saleRoutine
    Aug 10 same day

    Sold 7,750 shares at $109.01 ($845k)

    McGeorge Anne, Director

    10b5-1 planSold 100% of holdings ($845k position)0 shares leftFirst sale on recordFiling

  6. 6 Form 4 saleRoutine
    Aug 19 +9 days

    Sold 2,778 shares at $117.55 ($327k)

    Read Simon, Director

    10b5-1 planSold 100% of holdings ($327k position)0 shares leftFiling

  7. 7 Form 4 saleRoutine
    Sep 1 +13 days

    Sold 23,124 shares at $106.41 ($2.5M)

    Randhawa Simrat, EVP, Head of R&D

    10b5-1 planSold 85.3% of holdings ($2.9M position)4,000 shares left0.7x usual sizeFiling

  8. 8 Form 4 saleRoutine
    Sep 17 +16 days

    Sold 20,000 shares at $101.38 ($2M)

    Carr Edward, CHIEF ACCOUNTING OFFICER

    10b5-1 planSold 100% of holdings ($2M position)0 shares leftFiling

Every transaction

Loading transactions…

Sales, notices and lockups (55)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for DNTH
Source
Sep 17, 2026Carr EdwardCHIEF ACCOUNTING OFFICERForm 4 sale20,000$2M100.0%RoutineSEC
Sep 1, 2026Randhawa SimratEVP, Head of R&DForm 4 sale23,124$2.5M85.3%RoutineSEC
Aug 19, 2026Read SimonDirectorForm 4 sale2,778$327k100.0%RoutineSEC
Aug 10, 2026McGeorge AnneDirectorForm 4 sale7,750$845k100.0%RoutineSEC
Aug 10, 2026Veness Adam MSVP, General Counsel and Sec.Form 4 sale20,000$2.2M100.0%RoutineSEC
Aug 10, 2026Read SimonDirectorForm 4 sale2,777$304k100.0%RoutineSEC
Aug 7, 2026Garcia MarinoCEO AND PRESIDENTForm 4 sale166,000$17.9M71.8%RoutineSEC
Jul 9, 2026Savitz RyanEVP, CFO & CBOForm 4 sale31,249$3.2M100.0%RoutineSEC
Jun 17, 2026Veness Adam MSVP, General Counsel and Sec.Form 4 sale30,000$2.4M100.0%RoutineSEC
Jun 1, 2026Randhawa SimratEVP, Head of R&DForm 4 sale26,530$2.4M86.9%RoutineSEC
May 8, 2026Soteropoulos PaulaDirectorForm 4 sale599$51k100.0%RoutineSEC
Apr 9, 2026Savitz RyanEVP, CFO & CBOForm 4 sale8,224$739k100.0%RoutineSEC
Mar 31, 2026Savitz RyanEVP, CFO & CBOForm 4 sale114,367$9.5M100.0%RoutineSEC
Mar 31, 2026Soteropoulos PaulaDirectorForm 4 sale599$48k100.0%RoutineSEC
Mar 24, 2026Soteropoulos PaulaDirectorForm 4 sale27,594$2.2M100.0%RoutineSEC
Mar 12, 2026Randhawa SimratEVP, Head of R&DForm 4 sale33,830$2.8M100.0%RoutineSEC
Mar 12, 2026Garcia MarinoCEO AND PRESIDENTForm 4 sale122,918$10M100.0%RoutineSEC
Mar 12, 2026Carr EdwardCHIEF ACCOUNTING OFFICERForm 4 sale43,682$3.6M100.0%RoutineSEC
Dec 4, 2025Savitz RyanCFO & CBOForm 4 sale20,000$904k100.0%RoutineSEC
Nov 14, 2025Randhawa SimratEVP, Head of R&DForm 4 sale196,538$7.4M98.0%RoutineSEC
Sep 9, 2025Savitz RyanCFO & CBOForm 4 sale20,000$700k100.0%RoutineSEC
Feb 8, 2023Trv Gp IV, LLC10% ownerForm 4 sale3.7M$3.1M54.7%UnusualSEC
Sep 16, 2021Stants KristenChief People OfficerForm 4 sale5,736$39k28.7%UnusualSEC
Sep 16, 2021Mahoney Stephen F.OfficerForm 4 sale5,736$39k28.7%UnusualSEC
Sep 16, 2021Deardorf CarenChief Commercial OfficerForm 4 sale6,238$42k31.2%UnusualSEC
Sep 16, 2021Gardner JasonOfficerForm 4 sale14,340$97k4.8%UnusualSEC
Sep 16, 2021Beetham Thomas W.OfficerForm 4 sale6,103$41k30.5%UnusualSEC
Sep 16, 2021Olson LisaOfficerForm 4 sale5,736$39k28.7%UnusualSEC
Sep 16, 2021Nichols David WayneChief Technical OfficerForm 4 sale5,694$38k28.5%UnusualSEC
Jan 10, 2020Gardner JasonOfficer, DirectorForm 4 sale11,200$171k4.3%Plan not statedSEC
Jan 2, 2020Davis John C. JrChief Medical OfficerForm 4 sale11,294$170k57.6%UnusualSEC
Jan 2, 2020Gardner JasonOfficer, DirectorForm 4 sale2,800$42k1.1%Plan not statedSEC
Dec 24, 2019Isacson Christina K.Chief Business OfficerForm 4 sale4,463$71k5.1%Plan not statedSEC
Dec 24, 2019Zdraveski ZoranOfficerForm 4 sale7,902$126k5.8%Plan not statedSEC
Dec 23, 2019Zdraveski ZoranOfficerForm 4 sale4,181$67k3.0%Plan not statedSEC
Dec 23, 2019Isacson Christina K.Chief Business OfficerForm 4 sale9,867$158k10.1%Plan not statedSEC
Dec 23, 2019Gardner JasonOfficer, DirectorForm 4 sale2,897$44k1.1%Plan not statedSEC
Dec 20, 2019Gardner JasonOfficer, DirectorForm 4 sale76,711$1.2M22.2%Plan not statedSEC
Dec 20, 2019Davis John C. JrChief Medical OfficerForm 4 sale919$14k10.0%Plan not statedSEC
Dec 10, 2019Gardner JasonOfficer, DirectorForm 4 sale4,392$66k1.3%Plan not statedSEC
Dec 10, 2019Davis John C. JrChief Medical OfficerForm 4 sale21,669$325k72.3%UnusualSEC
Dec 2, 2019Cooke Michael P.Chief Scientific OfficerForm 4 sale7,500$98k3.0%Plan not statedSEC
Nov 20, 2019Cooke Michael P.Chief Scientific OfficerForm 4 sale5,000$60k2.0%Plan not statedSEC
Nov 1, 2019Cooke Michael P.Chief Scientific OfficerForm 4 sale5,000$53k1.9%Plan not statedSEC
Oct 1, 2019Cooke Michael P.Chief Scientific OfficerForm 4 sale5,000$50k1.9%Plan not statedSEC
Sep 19, 2019Cooke Michael P.Chief Scientific OfficerForm 4 sale1,656$20k0.6%Plan not statedSEC
Sep 12, 2019Cooke Michael P.Chief Scientific OfficerForm 4 sale844$10k0.3%Plan not statedSEC
Sep 3, 2019Cooke Michael P.Chief Scientific OfficerForm 4 sale5,000$51k1.8%Plan not statedSEC
Aug 1, 2019Cooke Michael P.Chief Scientific OfficerForm 4 sale7,500$101k2.7%Plan not statedSEC
Jul 1, 2019Cooke Michael P.Chief Scientific OfficerForm 4 sale7,500$108k2.6%Plan not statedSEC
Jun 21, 2019Isacson Christina K.Chief Business OfficerForm 4 sale5,415$87k5.2%Plan not statedSEC
Jun 21, 2019Gardner JasonOfficer, DirectorForm 4 sale14,000$212k3.9%Plan not statedSEC
Jun 17, 2019Cooke Michael P.Chief Scientific OfficerForm 4 sale7,500$104k2.6%Plan not statedSEC
Mar 20, 2019Atlas Venture Associates X, LLC10% ownerForm 4 sale14,245$254k100.0%UnusualSEC
Mar 20, 2019Booth BruceDirectorForm 4 sale14,245$254k100.0%UnusualSEC